Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS

European Journal of Haematology

Volumn 88, Issue 6, 2012, Pages 549-550

  Warsame, Rahma ^a   Kohut, Ingrid E ^b   Dispenzieri, Angela ^a  

^a MAYO CLINIC   (United States)

^b PA Oncology Hematology Association   (United States)

Author keywords

POEMS; Treatment

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN A; LENALIDOMIDE; VASCULOTROPIN;

ADULT; ANASARCA; ARTICLE; ASCITES; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FACE RASH; GYNECOMASTIA; HEPATOSPLENOMEGALY; HUMAN; HYPERPIGMENTATION; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE ATROPHY; NEUROPATHY; NIGHT SWEAT; OSTEOSCLEROSIS; PARACENTESIS; PERIPHERAL NEUROPATHY; PLEURA EFFUSION; POEMS SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RELAPSE; TREATMENT OUTCOME; TREATMENT RESPONSE; WASTING SYNDROME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HUMANS; MALE; PARANEOPLASTIC SYNDROMES; POEMS SYNDROME; PYRAZINES; RECURRENCE;

EID: 84861195971     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01780.x     Document Type: Article

References (7)

1. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285-99.
2. Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 1999;34:633-8.
3. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome [letter]. Lancet 1996;347:702.
4. Wang X, Ye S, Xiong C, Gao J, Xiao C, Xing X. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease. Jpn J Clin Oncol 2011;41:1221-4.
5. Ohguchi H, Ohba R, Onishi Y, et al. Successful treatment with bortezomib and thalidomide for POEMS syndrome. Ann Hematol 2011;90:1113-4.
6. Tang X, Shi X, Sun A, et al. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009;83:609-10.
7. Reeder CB, Reece DE, Kukreti V, et al. Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma. Blood 2010;115:3416-7.